Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:
Schedule
Product: Active Ingredient:
Dosage Form: New Zealand Sponsor: Manufacturer:
|
Montelukast Montelukast sodium 4.15mg equivalent to 4mg montelukast free acid Chewable tablet REX Medical Limited Cipla Limited, Verna, India
|
Product: Active Ingredient:
Dosage Form: New Zealand Sponsor: Manufacturer:
|
Montelukast Montelukast sodium 5.19mg equivalent to 5mg montelukast free acid Chewable tablet REX Medical Limited Cipla Limited, Verna, India
|
Product: Active Ingredient:
Dosage Form: New Zealand Sponsor: Manufacturer:
|
Montelukast Montelukast sodium 10.38mg equivalent to 10mg montelukast free acid Film coated tablet REX Medical Limited Cipla Limited, Verna, India
|
Product: Active Ingredients:
Dosage Form: New Zealand Sponsor: Manufacturer:
|
Sennadoc Docusate sodium 50mg Sennoside A+B calcium 42mg equivalent to 8mg senna Film coated tablet AFT Pharmaceuticals Limited Sigma Laboratories Limited, Mapusa, India
|
Dated this 12th day of May 2017.
CHRIS JAMES, Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).